The development of arteriosclerotic lesions in the Lewis to F344 rat model of chronic cardiac rejection is characterized by macrophage adhesion to the vessel lumen and macrophage infiltration in the neointima prior to smooth muscle cell accumulation. We report the cloning and characterization of allograft inflammatory factor-i (AIF-1), a novel cDNA that is expressed early and persistently in chronically rejecting cardiac allografts but is absent in cardiac syngrafts and host hearts. The full-length cDNA codes for a hydrophilic polypeptide of 17 kD that contains a 12-amino acid region similar to an EF-hand (calcium-binding) domain. In cardiac allografts AIF-1 transcripts and protein localized to infiltrating mononuclear cells. Analysis of isolated cell populations confirmed that AIF-1 was selectively expressed in macrophages and neutrophils and demonstrated that AIF-1 transcripts could be upregulated by sixfold after stimulation with the T cell-derived cytokine IFN-y. Treatment with a diet deficient in essential fatty acids (which attenuates arteriosclerosis) or CTLA-4 Ig (which blocks lymphocyte activation) significantly decreased AIF-1 transcript levels. Upregulation of AIF-1 in the setting of T cell activation suggests that it may play a role in macrophage activation and function. (J. Clin. Invest. 1995. 95:2954-2962
Introduction
The major manifestation of chronic cardiac rejection is transplant arteriosclerosis (1) (2) (3) . It is the leading cause of graft failure and retransplantation after the first postoperative year. Little is known about the pathogenesis of this diffuse, concentric intimal thickening that affects a spectrum of vessels in transplanted hearts. Because arterial lesions typically occur in donor vessels and are absent in recipient vessels, the development of arteriosclerosis appears to reflect a localized immune-mediated process. The most widely held hypothesis is that an alloimmune response involving activated inflammatory cells and vascular cells produces cytokines and growth factors that in turn mediate smooth muscle-cell migration and proliferation.
Animal models of cardiac transplantation have provided a way to evaluate the cellular and molecular components of transplant arteriosclerosis (4, 5) . Detailed immunocytochemical analyses of specific inflammatory cell types that are present at various times in the Lewis to F344 rat cardiac allograft model point to a key role for the macrophage (6, 7) . Arteriosclerotic lesions in vessels from Lewis to F344 rat cardiac allografts develop in stages. The earliest (7) (8) (9) (10) (11) (12) (13) (14) d) involves the adhesion of mononuclear cells to the vessel lumen. By day 30 an early neointima forms that is composed predominantly of infiltrating macrophages with some T lymphocytes. Between days 30 and 75 a actin-positive smooth muscle cells appear in the thickened neointima interposed among the inflammatory cells. Neointimal expansion is most striking after 100 d at which point it is often obliterative, with a predominance of smooth muscle cells and diminishing numbers of inflammatory cells.
Recent studies completed in our lab have examined the role of macrophages in the pathogenesis of chronic rejection and have demonstrated that macrophage activation occurs within the transplanted heart in concert with increased expression of inducible effectors such as monocyte chemoattractant protein-1, inducible nitric oxide synthase, and galactose/N-acetylgalactosamine macrophage lectin (8) (9) (10) . Macrophage activation and diversity are regulated in part by alterations in gene expression ( 11) . Thus, one of our goals has been to study the macrophage directly in the transplanted heart as a way of preserving the multiple cell types and stimuli that regulate its functional state. One approach has involved using differential mRNA display to identify genes whose expression increases in cardiac allografts undergoing chronic rejection in comparison with cardiac syngrafts (12) . These studies resulted in the identification of a novel cDNA fragment that we termed allograft inflammatory factor-I (ALF-1).' The purpose of the present study was to isolate the full-length AIF-1 cDNA and characterize its expression in vivo during various stages of chronic rejection and in vitro after cytokine stimulation. We demonstrate that the T cell-derived cytokine IFN-y up-regulates ALF-1 expression, suggesting a possible functional role for AIF-1 in macrophage activation and function.
Methods
Lewis to F344 rat cardiac transplantation. The heterotopic abdominal cardiac transplantation samples used in this study were originally procured in experimental sets described previously (9, 13, 14) . For allogeneic combinations, F344 rats were used as recipients and Lewis rats were used as donors. For syngeneic combinations Lewis rats served as recipients and donors. At the time of harvest both the host (recipient) heart, which served as a reference exposed to the same circulation, and the transplanted heart were collected for histologic analysis and RNA extraction.
Inflammatory cell populations. A lymphocyte-enriched cell population was obtained by purifying isolated splenocytes on nylon wool (9) . Peritoneal inflammatory rat macrophages were elicited with thioglycolate medium or the bacille Calmette Guerin as described (9, 15) . Rat bone marrow-derived macrophages were obtained by growing femoral bone marrow cells from Lewis rats in tissue culture medium containing murine macrophage colony stimulating factor-1 for 1 wk (9). More than 95% of these cells stained positive for ED-l and were thus judged to be of a monocyte/macrophage lineage. Culture medium was replaced with medium not containing macrophage colony stimulating factor-1 24 h before stimulation. Rat peritoneal neutrophils were obtained by casein elicitation according to a protocol originally described for Guinea pigs, except that 9% casein was used (16) 20 ug of total RNA as described (12) . Genomic DNA was isolated and digested with the indicated restriction endonucleases, electrophoresed through 0.8% agarose gels, and transferred to nitrocellulose (Micron Separations, Westboro, MA) by capillary transfer as described (17) . Hybridization with cDNA probes labeled with 32P dCTP by random priming (Boehringer-Mannheim Corp., Indianapolis, IN) and high-stringency washes (0.2xSSC, 0.1% SDS at 60°C) were performed as described (12) .
Semiquantitative reverse-transcriptase PCR assay. To conserve RNA, we used a modified reverse-transcriptase PCR technique to study AJF-1 transcript levels instead of Northern blot analysis (9, 18) . These reverse-transcriptase PCR assays are sensitive, require only 2.5 /ig total RNA, and permit replicates to be performed from a single cDNA preparation (18) . cDNA synthesis was completed with random primers (2.5 /g of total RNA per reaction). Oligonucleotides were synthesized by Genosys Biotechnologies, Inc. (The Woodlands, TX). To amplify rat cDNAs we used the 5' primer GTCAATTCGCTATGAGCCAGA-GCAAG and the 3' primer GAAGAAGCAGTTGTGAGCGTCGAC-CAA, a combination that resulted in a 543-bp product. For murine and human cDNAs we used an internal set of primers, 5' ATCCCAAGT-ACAGCAGTGATGAGG and 3' GTCCCCCAGCCAAGAAAGCTA-TTT, which generated a 329-bp PCR product. Reaction conditions were as described (9) . The (9) . Negative controls included omission of the primary antiserum, use of preimmune serum, and use of an irrelevant primary antiserum.
In vitro and in vivo regulation of AIF-J transcript levels. In vitro stimulation studies of various macrophage cells or cell lines were completed using rat IFN-y (100 U/ml) (GIBCO BRL, Gaithersburg, MD), phorbol 12-myristate-13-acetate (50 ng/ml) (Sigma), or LPS (100 ng/ ml) (Escherichia coli serotype 011 1:B4; Sigma). To study whether strategies that impair T cell activation in vivo would alter AIF-1 transcript levels, we evaluated cDNA samples from two series of transplants performed previously. In the first series the cDNAs were prepared from transplanted and host hearts harvested at day 7 and 28 from recipients fed an anti-inflammatory, essential fatty acid-deficient (EFAD) diet or a control diet (13) . In the second transplant series the recombinant fusion protein CTLA4 Ig (Bristol-Myers Squibb, Seattle, WA), which blocks the CD28/B7 costimulatory pathway, was used to inhibit T cell activation in chronic cardiac rejection (14) . CTGAGGAGCTATGAGCCAGAGCAAGGATTTGCAGGAGGAAAAGCTTTTGGACTGCTGAA 120 such as mouse tropomn C (51% similar or identical amino acids) (22) and human calmodulin (48% similar or identical amino acids) (23). Sandoz, Basel, n = 3). These samples were compared
The AIF-1 cDNA hybridized to genomic DNA from rats, om day-75 syngrafts (n = 3) and an untreated (refermice, and humans ( Fig. 2) , demonstrating evolutionary conserurdiac allograft (n = 1).
vation across these species. (Fig. 1 B) predicted a hydrophilic polypeppression in testis has been extensively studied but is the subject ignificant hydrophobic stretches, which are usually of another report.) th membrane-spanning proteins.
AIF-J gene expression increases in cardiac allografts over searches revealed homology with genomic setime. To study AIF-1 gene expression patterns after cardiac ined from a 90-kb segment of the human HLA transplantation, we measured relative transcript levels with a in (which had been systematically sequenced in a reverse-transcriptase PCR assay which requires 10-fold less rt) (20) . Homology ranged from 68-93% over RNA and permits analysis of replicates. cDNAs derived from 7-1 cDNA sequence. Alignment was identified in cardiac allografts were compared with those from paired host b upstream of the BAT-2 gene. To date no coding hearts harvested at various stages of chronic rejection. As seen ie been submitted to the GenBank and EMBL data in the representative analysis that included two transplants from 2956 Utans et al. each time point (Fig. 4) , AIF-l transcript levels were significanfly higher in cardiac allografts (days 7, 28, 75) in comparison with paired host hearts, which had been exposed to the same circulation but had no histologic abnormalities (P < 0.003). Transcript levels were also significantly higher in day-75 cardiac allografts (n = 2) compared with day-75 cardiac syngrafts (n = 2) (P < 0.0001). ALF-1 transcript expression peaked at day 28, with cardiac allograft levels significantly higher in comparison with those at both days 7 and 75 (P < 0.001) in two separate experimental sets. These findings confirm the allograft-specific and time-dependent expression of AIF-1 transcripts originally observed in Northern blot studies in which the AIF-1 3' cDNA fragment had been used as probe (12) . In situ localization of AIF-I mRNA to inflammatory infil- Figure 5 . In situ localization of AIF-l transcripts in rat cardiac allografts.
Frozen sections were hybridized with 3"S-UTP-labeled antisense (A x300) and sense (B x300) riboprobes. Silver grains indicating hybridization of AIF-1 mRNA are clustered over mononuclear inflammatory cells in the perivascular (arrow) and interstitial spaces.
trates within cardiac allografts. In Fig. 5 A silver grains indicating hybridization of the AIF-1 antisense riboprobe are seen to cluster over regions of inflammatory cell infiltrates in cardiac allograft sections, and they do not cluster over myocytes. Positive hybridization was predominately in the interstitium and perivascular spaces. In splenic tissue, silver grains associated with ALF-1 mRNA were identified primarily in regions within the red pulp (not shown). There was no significant hybridization to host hearts (not shown) or when the sense probe was used (Fig. 5 B) . In sections from rat and mouse testis, silver grains associated with AIF-1 mRNA were concentrated over differentiated germ cells in the seminiferous tubules (not shown). AIF-I transcript levels in inflammatory cell populations. To further characterize the cell type(s) that express AIF-1 transcripts, we analyzed a series of isolated rat cell populations by Northern blotting (Fig. 6, A and B (Fig. 8 A) . The positive cells showed a cytoplasmic staining pattern and were found in regions of perivascular and interstitial infiltration. Besides these inflammatory mononuclear cells, none of the parenchymal cell types within the cardiac allograft stained positive. In splenic tissue scattered positive cells were identified predominately in the red pulp (Fig. 8 B) . There was also a rim of positive cells just adjacent to the white pulp. In testis the AIF-1 antigen localized predominately to germ cells and occasionally to monocyte/macrophages (not shown), suggesting that it may play a distinct role in this tissue-perhaps in germ cell differentiation. In all cases, no significant staining was seen when the primary antibody was omitted or when preimmune serum was used.
In vitro upregulation ofAIF-J transcripts in IFN-y-treated macrophages. We have recently shown that the expression of the T cell-derived cytokine IFN-y is persistently upregulated in chronically rejecting cardiac allografts (14) . To (Fig. 9 A) , AIF-1 transcript levels increased significantly (fivefold) 24 h after stimulation with IFN-y in comparison with cells stimulated with phorbol 12-myristate-13-acetate or LPS (P < 0.0001). In contrast, the addition of LPS antagonized IFN-y-induced expression of AIF-1, as has been reported for other macrophage factors (24, 25 ) . AIF-1 transcript levels did not change significantly at 4 and 10 h with any of the stimulants studied. A more detailed time-course study of the IFN-y response showed that the increase in AIF-1 transcripts was delayed, peaking in J774A.1 cells at 36 h after stimulation (Fig. 9 B) . The most effective dose of IFN-y was 100 U/ml of medium (Fig. 9 C) . Immunoblotting confirmed these time-and dose-dependent increases in AIF-1 expression (data not shown). This late increase in AIF-1 expression suggests that its up-regulation by IFN-y may be an indirect effect.
In vivo modulation of T cell activation reduces AIF-J transcripts in cardiac allografts. To study the regulation of AIF-1 expression in vivo we applied strategies that attenuate T cell activation and reduce IEN-y expression. Modulation of the inflammatory response with an EFAD diet decreases expression of IFN-y at day 28, reduces mononuclear cell infiltration, and attenuates arteriosclerotic development in Lewis to F344 cardiac allografts (13) . Here we show that ALF-1 transcript levels in 28-d cardiac allografts on the EFAD diet were reduced significantly in comparison with those in allografts from recipients fed a control diet (P < 0.0001) (Fig. 10 A) . In contrast, at day 7 (before the EFAD diet has its effect), there was no significant difference in AIF-1 transcript levels in allografts on the EFAD diet versus the control diet. AIF-1 transcript levels in host hearts were uniformly low. 2958 Utans et al. Preliminary studies from our laboratory indicate that blocking the CD28/B7 costimulatory pathway of T cell activation with CTLA-4 Ig prolongs allograft survival, reduces mononuclear cell infiltration, and prevents T cell and macrophage activation in the Lewis to F344 rat model ( 14) . AIF-1 transcript levels were reduced significantly in cardiac allografts from recipients treated with CTLA-4 Ig in comparison with untreated allografts or cyclosporine A-treated (single dose on day 2) allografts (P < 0.0001) (Fig. 10 B) . The most dramatic decrease was seen in the group that received CTLA-4 Ig in addition to donor cells on the day of engraftment. AIF-1 transcript levels in this group were significantly lower than those in cardiac allografts that received CTLA-4 Ig alone (P < 0.0001) and similar to those seen in control syngrafts. The decrease in AIF-1 expression in cardiac allografts treated with the EFAD diet and with CTLA-4 Ig corresponded to a reduction in the number of ED-l -positive macrophages. Thus, in cardiac allografts treated with CTLA-4 Ig there was a decrease in AIF-1 transcripts that reflected the decrease in macrophage density. However, a direct or indirect effect of CTLA-4 Ig on AIF-1 expression may also contribute.
Discussion
Here we report the cloning of AIF-1 cDNA and the characterization of its expression in vivo and in vitro. The 3' portion of the AIF-l cDNA was originally identified in a screen for differentially expressed genes present in cardiac allografts compared with reference syngrafts (12) . The strategy was to analyze cDNAs from the cardiac allografts directly, as a way of preserving the infiltrating macrophages and the allogeneic microenvironment that regulated their functional state. Our further characterization of AIF-1 has demonstrated that it is a novel factor selectively expressed by inflammatory cells of the monocyte/ neutrophil lineage and up-regulated by IFN-y, although not necessarily specific for allogeneic inflammation. The high levels of AIF-1 in allografts reflected in part the high density of infil- in syngrafts and paired host hearts (exposed to the same circulation but with normal vessels) (12) . More extensive studies completed with a series of cardiac transplants harvested at various time points showed that AIF-l transcripts increased significantly in allografts by day 7 and remained elevated through days 28 and 75. In contrast, AIF-1 levels were low in paired host hearts. This early and sustained expression of ALF-1 is consistent with an ongoing allogeneic inflammatory stimulation, as might be expected in chronic rejection.
In cellular localization studies performed with cardiac allograft and splenic tissue sections, AIF-1 localized to mononuclear cells and was found predominantly in regions occupied by macrophages. In cardiac allografts, ED-i -positive macrophages have been shown to be the predominant infiltrating cell type in the interstitium and perivascular space (7) . Hence, the AIF-l -positive cells described here are most likely macrophages. In the spleen AIF-1 staining was found in the red pulp within a subset of cells with macrophage features, and in cells forming a rim in the white pulp typical of marginal macrophages (27) . In contrast, in the testis there was a very high level of expression of AIF-1 mRNA and antigen by differentiating germ cells (data not shown), suggesting that AIF-l has a distinct role in spermatogenesis as opposed to inflammation. In vitro studies of isolated cells and cell lines from rats, mice, and humans also confirmed the selective expression of AIF-1 by cells of the monocyte/macrophage lineage, in comparison with cells of the lymphoid lineage. AIF-l was also expressed by elicited neutrophils, a cell type seen infrequently in cardiac allografts and spleen.
Myeloid specificity is a feature shared by other members of the EF-hand family. The best studied examples are MRP8/ MRP14, which have been associated with a number of acute and chronic inflammatory diseases (28) , and murine CP-10, a chemotactic protein for neutrophils and monocytes (29) . Like AIF-1, these proteins lack classic signal sequences. This lack raises questions about whether they attain extracellular bioactivity at cell death or through alternative transport mechanisms. Studies in vitro and in vivo have shown that the hinge region between the two EF-hands of CP-10 contributes significantly to its chemotactic activity (30) . Further studies will be needed to determine whether AIF-1 functions in the recruitment of cells to sites of injury.
We also studied the regulation of AIF-1 expression in vitro and in vivo. We have shown that a number of inflammatory mediators associated with T cell activation (IFN-y) and macrophage activation (monocyte chemoattractant protein-i and inducible nitric oxide synthase) are up-regulated in Lewis to F344 rat cardiac allografts undergoing chronic rejection (8, 10, 18 ( 13, 14) . We examined whether these two different strategies would affect the levels of AIF-1 transcripts in vivo. The antiinflammatory effect of the EFAD diet results from defects in arachidonate metabolism and leukotriene production (which impair leukocyte chemotaxis and function) in rodent models of inflammation that include glomerulonephritis (32) . In Lewis to F344 rat cardiac allografts the EFAD diet reduces mononuclear cell infiltration, the severity of intimal thickening, and the number of vessels with intimal thickening that develop at early (day 28) as well as late (day 120) stages ( 13, 33) . In this report we show that there was a significant reduction in the number of AIF-1 transcripts in day 28 cardiac allografts treated with the EFAD diet in comparison with day 28 allografts on a control diet. This reduction in AIF-I transcripts could be due to attenuation of leukocyte infiltration or to leukocyte activation and production of cytokines such as IFN-y, or both.
CTLA-4 Ig is a recombinant fusion protein that inhibits the CD28/B7 costimulatory pathway required for activation of lymphocytes (34) . CTLA-4 Ig has been shown to prolong graft survival in rat and mouse acute rejection models (35, 36) , but little is known about its effect on macrophages. We show here that cardiac allografts treated with CTLA-4 Ig had lower AIF-1 transcript levels (correlating with a reduction in mononuclear cell infiltration) than transplants receiving the control treatment (a single dose of cyclosporine A) and untreated animals. The perioperative administration of donor cells in addition to CTLA- 4 Ig was associated with minimal mononuclear cell infiltration, and it resulted in a further decrease in AIF-1 transcripts, to levels similar to those seen in syngrafts. The effect of CTLA- 4 Ig alone may be incomplete, that is, it may only delay inhibition of T cell activation and require repeated administration. However, with the increased availability of alloantigen supplied by donor cells it may be possible to produce a long-lasting tolerance due to clonal deletion of the alloantigen-specific T cell population. Our observation that expression of AIF-1 was attenuated by CTLA-4 Ig treatment in Lewis to F344 rat allografts suggests that T cell activation regulates this macrophage component of the alloimmune response associated with chronic cardiac rejection.
The identification of the novel myeloid factor AIF-1 in the cytokine-rich milieu of cardiac allografts links it to the alloimmune response associated with chronic rejection and highlights the prominence of macrophages in this process. From a practical standpoint, measurement of AIF-I transcript or expression levels may be useful in evaluating macrophage infiltration, and it may serve as a clinical marker of chronic cardiac rejection. Our in vitro studies provide evidence that AIF-I is a cytokineresponsive molecule that can be upregulated by IFN-y, a product of activated T cells. The in vivo studies demonstrate that AIF-1 transcript levels decrease in accord with monocyte infiltration when IFN-y expression is attenuated in cardiac allografts treated with CTLA-4 Ig or the EFAD diet. This modulation of AIF-I expression may be an indirect result of alterations in expression of cytokines or chemokines such as IFN-y within the graft. Alternatively, these treatments may have direct effects on AIF-1 transcription. The next step will be to determine whether the effect of these treatments is due to alterations in the degree of macrophage infiltration or impaired macrophage activation. Additional strategies for inhibiting various components of T cell activation in vivo will be helpful in determining the specific factors that regulate AIF-1 expression and, ultimately, its functional role in macrophage biology.
